本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Immunovant, Inc.

37.36
-0.7400-1.94%
盤後36.83-0.5300-1.42%19:30 EDT
成交量:103.19萬
成交額:3,866.83萬
市值:77.11億
市盈率:-13.26
高:38.93
開:38.62
低:37.19
收:38.10
52周最高:45.42
52周最低:14.58
股本:2.06億
流通股本:8,956.68萬
量比:0.92
換手率:1.15%
股息:- -
股息率:- -
每股收益(TTM):-2.8178
每股收益(LYR):-2.7716
淨資產收益率:-80.10%
總資產收益率:-46.73%
市淨率:10.49
市盈率(LYR):-13.48

資料載入中...

2020/08/25

重要事件披露

8-K - Current report
2020/08/21

重要事件披露

8-K - Current report
2020/08/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/12

重要事件披露

8-K - Current report
2020/06/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/29

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/06/29

重要事件披露

8-K - Current report
2020/06/15

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/05/15

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/14

重要事件披露

8-K - Current report
2020/04/17

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/10

招股説明書

General form for registration of securities under the Securities Act of 1933
2020/04/09

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/04/08

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/08

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2020/04/03

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/03/30

重要事件披露

8-K - Current report
2020/02/28

SEC問詢函

CORRESP [Cover] - Correspondence